Renal Division, Department of Medicine, Emory University, Atlanta, GA, USA.
Nephrol Dial Transplant. 2012 Feb;27(2):521-6. doi: 10.1093/ndt/gfr375. Epub 2011 Jul 7.
Thiosulfate has been shown to inhibit vascular calcification in uremic rats and may inhibit calcification in humans with end-stage renal disease but whether this is due to a systemic or local action is unknown. The underlying mechanism is also unclear but complexation of calcium ions has been proposed.
In vitro assays were used to determine the effect of thiosulfate on vascular calcification and hydroxyapatite formation.
Thiosulfate (EC50: 1-2 mM) prevented calcification of injured or devitalized aortas but not uninjured aortas, and similar results were obtained with sulfate. There was no effect on reversal of calcification. Measurements with an ion-sensitive electrode (corrected for changes in ionic strength) revealed a very weak interaction between thiosulfate and Ca(2+) (K(a) = 10.9 ± 1.0 × 10(-6) M(-1)) that resulted in a 4% decrease in ionized Ca(2+) in culture medium at 5 mM thiosulfate and a corresponding 5% increase in the solubility product for calcium-phosphate. Adjustment of the total Ca(2+) concentration to account for this did not prevent the inhibition of aortic calcification by thiosulfate. Thiosulfate did not inhibit hydroxyapatite formation from seed crystals or the calcification of purified elastin and did not alter medium pH.
Thiosulfate inhibits vascular calcification at millimolar concentrations through a direct extracellular effect that does not require intact smooth muscle cells but is related to cellular injury. This effect is not specific for thiosulfate since sulfate has similar properties. Inhibition cannot be explained by effects on ionized calcium, calcium-phosphate solubility, pH, oxidative stress or hydroxyapatite formation.
硫代硫酸盐已被证明可抑制尿毒症大鼠的血管钙化,并且可能抑制终末期肾病患者的钙化,但尚不清楚这是由于全身还是局部作用。其潜在机制尚不清楚,但已提出钙离子络合的作用机制。
采用体外测定法来确定硫代硫酸盐对血管钙化和羟基磷灰石形成的影响。
硫代硫酸盐(EC50:1-2 mM)可预防损伤或失活的主动脉钙化,但对未损伤的主动脉无作用,硫酸盐也有类似的作用。对钙化逆转无影响。用离子敏感电极进行的测量(校正离子强度变化)表明,硫代硫酸盐与 Ca(2+)(K(a) = 10.9 ± 1.0×10(-6) M(-1))的相互作用非常弱,导致在 5 mM 硫代硫酸盐的培养液中离子化 Ca(2+)降低 4%,钙-磷酸盐的溶度积增加 5%。调整总 Ca(2+)浓度以解释这一点,并不会阻止硫代硫酸盐抑制主动脉钙化。硫代硫酸盐不能抑制晶种诱导的羟基磷灰石形成或纯化弹性蛋白的钙化,也不会改变培养基 pH 值。
硫代硫酸盐以毫摩尔浓度抑制血管钙化,通过直接的细胞外作用,不需要完整的平滑肌细胞,但与细胞损伤有关。这种作用不是硫代硫酸盐所特有的,因为硫酸盐具有类似的特性。抑制作用不能用离子化钙、钙-磷酸盐溶解度、pH 值、氧化应激或羟基磷灰石形成来解释。